Accelerating · confidence 54%
Critical materials & rare earths
Two separate drivers with dates: gold at three-month highs (2026-08-21) with AEM's Radisson placement (2026-08-24) and a Jefferies Buy initiation on IAG at $24 (2026-08-21); and US materials policy — Trump's $1.55B rare-earth move (2026-08-24), MP surging (2026-08-21), AA's gallium plant groundbreaking (2026-08-24), CLF rallying on the 50% Canada tariff threat (2026-08-24). A gold reversal below the level that produced the 08-21 high would split this cluster in two, since the precious-metals and policy-metals legs share no common catalyst.
Dossiers in this theme → Accelerating · confidence 54%
Crypto exchanges & financials
Bitcoin above $77,000 (2026-08-21) and near $80,000 (2026-08-25) is carrying the whole cluster: MSTR raised $2B with holdings turned profitable on a 24% BTC move (2026-08-24), CRCL drew a Bernstein $140 case and a Susquehanna PT to $92 (2026-08-24), BMNR bought $81M of ether (2026-08-24), PURR moved on Trump's Hyperliquid comments (2026-08-20). This is beta to one price, not eight theses — a BTC round-trip back below the 08-21 level invalidates the theme, not just individual names.
Dossiers in this theme → Accelerating · confidence 26%
Housing, homebuilders & proptech
New and resting almost entirely on one name: JELD's one-month score (115.0) is more than triple its three-month (35.9) after appearing in an industrials movers list (2026-08-19), against US home-builder sentiment edging higher in August (08-17). PRCH is decelerating (1m 44.6 vs 3m 79.1) and OPEN has no data or headline at all — three tickers with one real signal is too small a sample to call a housing rotation, and a flat JELD week ends it.
Dossiers in this theme → Accelerating · confidence 55%
Medtech & diagnostics
Dated, name-level catalysts rather than tape alone: TEM FDA clearance for Tempus ECG-PH (2026-08-24), PSNL new VA MVP task order (2026-08-20), WGS Genetics in Medicine rapid-genome data (2026-08-24), TWST 52-week high the same day Scorpion Capital disclosed a short (2026-08-19). Status downgrades if the next two weeks bring only index-roundup mentions and no new clearance/contract prints.
Dossiers in this theme → Accelerating · confidence 48%
Oncology & immunology
The Moderna/Merck cancer-vaccine breakthrough coverage (2026-08-20) and 'Moderna Doubles' (2026-08-19) reset attention across mRNA names; ARCT's one-month score (157.7) now exceeds its three-month (102.7), the signature of new rather than carried momentum. The leader has already given back ground — MRNA slid on 2026-08-24 after the rally and its 3m score (197.3) sits above its 1m (157.8); a second down week in MRNA with no new trial data would make this maturing.
Dossiers in this theme → Accelerating · confidence 50%
Space economy
Policy is the fresh input: Trump's national space transportation policy targeting 1,000 launches a year by 2030 (2026-08-21), Goldman's $1.8T-by-2035 'Second Space Age' note (2026-08-18), the SpaceX IPO at a reported $1.77T valuation as a comp (2026-08-25), plus RKLB's share of a $981M Space Force test-infrastructure program (2026-08-18). Counter-evidence already present: YSS took three PT cuts and a Canaccord downgrade to Hold (2026-08-18 to 08-20) despite its own Space Force selection — policy headlines are not translating into estimate raises at every name.
Dossiers in this theme →